Cargando…
The Therapeutic Potential of Zinc-Alpha2-Glycoprotein (AZGP1) in Fibrotic Kidney Disease
Chronic kidney disease (CKD) is characterized by a long-term loss of kidney function and, in most cases, by progressive fibrosis. Zinc-alpha2-glycoprotein (AZGP1) is a secreted protein, which is expressed in many different tissues and has been associated with a variety of functions. In a previous st...
Autores principales: | Sörensen-Zender, Inga, Rong, Song, Haller, Hermann, Schmitt, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775758/ https://www.ncbi.nlm.nih.gov/pubmed/35054830 http://dx.doi.org/10.3390/ijms23020646 |
Ejemplares similares
-
Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease
por: Sörensen-Zender, Inga, et al.
Publicado: (2013) -
Changes in AZGP1 Serum Levels and Correlation With Pulse Wave Velocity After Kidney Transplantation
por: Kraemer, Thomas Daniel, et al.
Publicado: (2021) -
Development of a prediction model for mortality and cardiovascular outcomes in older adults taking into account AZGP1
por: Huscher, Dörte, et al.
Publicado: (2021) -
Alpha-2-Glycoprotein 1(AZGP1) Regulates Biological Behaviors of LoVo Cells by Down-Regulating mTOR Signaling Pathway and Endogenous Fatty Acid Synthesis
por: Chang, Ligong, et al.
Publicado: (2014) -
Retraction: Alpha-2-Glycoprotein 1(AZGP1) Regulates Biological Behaviors of LoVo Cells by Down-Regulating mTOR Signaling Pathway and Endogenous Fatty Acid Synthesis
Publicado: (2019)